The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth
- 31 May 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (5) , 497-503
- https://doi.org/10.1016/0145-2126(92)90176-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Type‐II estrogen binding sites in a lymphoblastoid cell line and growth‐inhibitory effect of estrogen, anti‐estrogen and bioflavonoidsInternational Journal of Cancer, 1990
- Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsBritish Journal of Cancer, 1990
- Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growthAnti-Cancer Drugs, 1990
- Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsBritish Journal of Haematology, 1990
- Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetinInternational Journal of Cancer, 1990
- The frequency of long‐term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow‐up time of 6 yearsBritish Journal of Haematology, 1989
- Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibitionJournal of Steroid Biochemistry, 1988
- Acute myelogenous leukemia: recent advances in therapyBlood, 1987
- A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trialBlood, 1984
- A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemiaBlood, 1984